Schedule 13G ownership disclosure

Corbus Pharmaceuticals Holdings, Inc.

Security class unavailable · CUSIP: 21833P103

Event date: 2017-02-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-17-012935
Form type
SC 13G/A
Filer
Corbus Pharmaceuticals Holdings, Inc.
CIK
CIK 1595097
Filed
Mar 06, 2017
Reporting period
Feb 28, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub